Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardiometabolic risk factor control in black and white people in the United States initiating sodium‐glucose co‐transporter‐2 inhibitors: A real‐world study
Olga Montvida, Subodh Verma, Jonathan E. Shaw, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 12, pp. 2384-2397
Open Access | Times Cited: 10

Showing 10 citing articles:

Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 14
Sodium-glucose cotransporter-2 inhibitors and incidence of atrial fibrillation in older adults with type 2 diabetes: a retrospective cohort analysis
Yujia Li, Huilin Tang, Yi Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Temporal trends in co‐morbidities and cardiometabolic risk factors at the time of type 2 diabetes diagnosis in the UK
Joanna Ling, Digsu N. Koye, Luke Buizen, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1150-1161
Closed Access | Times Cited: 14
Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK
John Dibato, Olga Montvida, Joanna Ling, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 2066-2077
Open Access | Times Cited: 9
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis
William Hinton, Michael Feher, Neil Munro, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Racial disparity in the co-occurrence of depression and type 2 diabetes mellitus. An electronic medical record study involving African American and White Caucasian adults from the US
John Dibato, Olga Montvida, Paul K. Sanjoy
Journal of Affective Disorders (2023) Vol. 330, pp. 173-179
Closed Access | Times Cited: 4
Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors
Katherine Young, Eram Haider McInnes, Robert Massey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Cardiorenal Complications in Young-Onset Type 2 Diabetes Compared Between White Americans and African Americans
Sanjoy K. Paul, Jonathan E. Shaw, Peter Fenici, et al.
Diabetes Care (2022) Vol. 45, Iss. 8, pp. 1873-1881
Open Access | Times Cited: 5
Robustness of Multiple Imputation Methods for Missing Risk Factor Data from Electronic Medical Records for Observational Studies
Sanjoy K. Paul, Joanna Ling, Mayukh Samanta, et al.
Journal of Healthcare Informatics Research (2022) Vol. 6, Iss. 4, pp. 385-400
Open Access | Times Cited: 3
Cardiometabolic risk factors and cardiovascular disease predictions in older African and European Americans
Trudy Moore-Harrison, Kivana Keane, L. Jerome Brandon
Preventive Medicine Reports (2022) Vol. 30, pp. 102019-102019
Open Access
Page 1

Scroll to top